General Information of the Compound
Compound ID
CP0569619
Compound Name
6-bromo-2-[(6-chloropyridin-3-yl)methyl]-3,4-dihydropyrazino[1,2-a]benzimidazol-1-one
    Show/Hide
Structure
Formula
C16H12BrClN4O
Molecular Weight
391.656
Canonical SMILES
Clc1ccc(CN2CCn3c(nc4cccc(Br)c34)C2=O)cn1
    Show/Hide
InChI
InChI=1S/C16H12BrClN4O/c17-11-2-1-3-12-14(11)22-7-6-21(16(23)15(22)20-12)9-10-4-5-13(18)19-8-10/h1-5,8H,6-7,9H2
    Show/Hide
InChIKey
VWSGTBDFTPWQRK-UHFFFAOYSA-N
Physicochemical Property
logP
3.5032
Rotatable Bonds
2
Heavy Atom Count
23
Polar Areas
51.02
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
4
Complexity
23

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 166633306
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01748, Metabotropic glutamate receptor 2
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000064 Chem-1 Rattus norvegicus (Rat)  1
1
EC50 = 540 nM
   TI
   LI
   LO
   TS